Select Medical Q4 EPS Misses by 31.6%, Revenue Up 7% to $1.40 Billion
Select Medical reported Q4 EPS of $0.16, missing estimates by 31.6% and down from $0.18 a year ago, while revenue rose 7.0% to $1.40 billion, topping forecasts by 2.6%. The company has Zacks Rank #4 and its Medical HMOs industry sits in the bottom 9%, despite shares climbing 9.9% YTD.
1. Q4 Financial Results
Select Medical posted Q4 EPS of $0.16, below the $0.23 consensus and down from $0.18 a year earlier. Revenue climbed 7.0% year-over-year to $1.40 billion, exceeding forecasts by 2.6%.
2. Estimate Surprises and Trends
The 31.6% EPS shortfall marked a reversal from the prior quarter’s 27.8% upside surprise. The company beat revenue estimates three of the past four quarters but has only surpassed EPS forecasts two times over the same period.
3. Market Performance and Industry Outlook
SEM shares have risen 9.9% year-to-date, outpacing the S&P 500’s 0.5% gain. The stock holds a Zacks Rank #4, reflecting unfavorable estimate revisions, while the Medical HMOs sector ranks in the bottom 9% of Zacks-tracked industries.